Bello AK, Okpechi IG, Osman MA, Cho Y, Htay H, Jha V, Wainstein M, Johnson DW (2022) Epidemiology of haemodialysis outcomes. Nat Rev Nephrol 18:378–395. https://doi.org/10.1038/s41581-022-00542-7

Article  PubMed  PubMed Central  Google Scholar 

Ogata H, Sugawara H, Yamamoto M, Ito H (2024) Phosphate and coronary artery disease in patients with chronic kidney disease. J Atheroscler Thromb 31:1–14. https://doi.org/10.5551/jat.RV22012

Article  CAS  PubMed  Google Scholar 

Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y (2014) Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int 85:174–181. https://doi.org/10.1038/ki.2013.327

Article  CAS  PubMed  Google Scholar 

Xiong J, He T, Wang M, Nie L, Zhang Y, Wang Y, Huang Y, Feng B, Zhang J, Zhao J (2019) Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis. J Nephrol 32:791–802. https://doi.org/10.1007/s40620-019-00601-6

Article  CAS  PubMed  Google Scholar 

Bressendorff I, Hansen D, Schou M, Silver B, Pasch A, Bouchelouche P, Pedersen L, Rasmussen LM, Brandi L (2017) Oral magnesium supplementation in chronic kidney disease stages 3 and 4: efficacy, safety, and effect on serum calcification propensity-a prospective randomized double-blinded placebo-controlled clinical trial. Kidney Int Rep 2:380–389. https://doi.org/10.1016/j.ekir.2016.12.008

Article  PubMed  Google Scholar 

Sakaguchi Y, Hamano T, Obi Y, Monden C, Oka T et al (2019) A randomized trial of magnesium oxide and oral carbon adsorbent for coronary artery calcification in predialysis CKD. J Am Soc Nephrol 30:1073–1085. https://doi.org/10.1681/asn.2018111150

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ter Braake AD, Shanahan CM, de Baaij JHF (2017) Magnesium counteracts vascular calcification: passive interference or active modulation? (in eng). Arterioscler Thromb Vasc Biol 37:1431–1445. https://doi.org/10.1161/atvbaha.117.309182

Article  PubMed  Google Scholar 

Zaslow SJ, Oliveira-Paula GH, Chen W (2024) Magnesium and vascular calcification in chronic kidney disease: current insights. Int J Mol Sci 25:1155. https://doi.org/10.3390/ijms25021155

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ter Braake AD, Tinnemans PT, Shanahan CM, Hoenderop JGJ, de Baaij JHF (2018) Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation. Sci Rep 8:2069. https://doi.org/10.1038/s41598-018-20241-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saidak Z, Brazier M, Kamel S, Mentaverri R (2009) Agonists and allosteric modulators of the calcium-sensing receptor and their therapeutic applications. Mol Pharmacol 76:1131–1144. https://doi.org/10.1124/mol.109.058784

Article  CAS  PubMed  Google Scholar 

Molostvov G, Fletcher S, Bland R, Zehnder D (2008) Extracellular calcium-sensing receptor mediated signalling is involved in human vascular smooth muscle cell proliferation and apoptosis. Cell Physiol Biochem 22:413–422. https://doi.org/10.1159/000185484

Article  CAS  PubMed  Google Scholar 

Alesutan I, Tuffaha R, Auer T, Feger M, Pieske B, Lang F, Voelkl J (2017) Inhibition of osteo/chondrogenic transformation of vascular smooth muscle cells by MgCl2 via calcium-sensing receptor. J Hypertens 35:523–532. https://doi.org/10.1097/hjh.0000000000001202

Article  CAS  PubMed  Google Scholar 

Kunutsor SK, Whitehouse MR, Blom AW, Laukkanen JA (2017) Low serum magnesium levels are associated with increased risk of fractures: a long-term prospective cohort study. Eur J Epidemiol 32:593–603. https://doi.org/10.1007/s10654-017-0242-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakaguchi Y, Hamano T, Wada A, Hoshino J, Masakane I (2018) Magnesium and risk of hip fracture among patients undergoing hemodialysis. J Am Soc Nephrol 29:991–999. https://doi.org/10.1681/asn.2017080849

Article  CAS  PubMed  Google Scholar 

Belluci MM, de Molon RS, Rossa C Jr., Tetradis S, Giro G, Cerri PS, Marcantonio E Jr., Orrico SRP (2020) Severe magnesium deficiency compromises systemic bone mineral density and aggravates inflammatory bone resorption. J Nutr Biochem 77:108301. https://doi.org/10.1016/j.jnutbio.2019.108301

Article  CAS  PubMed  Google Scholar 

Toba Y, Kajita Y, Masuyama R, Takada Y, Suzuki K, Aoe S (2000) Dietary magnesium supplementation affects bone metabolism and dynamic strength of bone in ovariectomized rats. J Nutr 130:216–220. https://doi.org/10.1093/jn/130.2.216

Article  CAS  PubMed  Google Scholar 

Rude RK, Gruber HE, Norton HJ, Wei LY, Frausto A, Kilburn J (2005) Dietary magnesium reduction to 25% of nutrient requirement disrupts bone and mineral metabolism in the rat. Bone 37:211–219. https://doi.org/10.1016/j.bone.2005.04.005

Article  CAS  PubMed  Google Scholar 

Katsumata S, Matsuzaki H (2023) Short-term dietary magnesium deficiency downregulates the expression of bone formation-related genes in rats. Magnes Res 36:23–29. https://doi.org/10.1684/mrh.2023.0518

Article  PubMed  Google Scholar 

Barman Balfour JA, Scott LJ (2005) Cinacalcet hydrochloride. Drugs 65:271–281. https://doi.org/10.2165/00003495-200565020-00007

Article  PubMed  Google Scholar 

Schepelmann M, Ranieri M, Lopez-Fernandez I, Webberley TS, Brennan SC et al (2022) Impaired mineral ion metabolism in a mouse model of targeted calcium-sensing receptor (CaSR) deletion from vascular smooth muscle cells. J Am Soc Nephrol 33:1323–1340. https://doi.org/10.1681/asn.2021040585

Article  CAS  PubMed  PubMed Central  Google Scholar 

Engeßer J, Albert PG, Scheuch M, Loth N, Stracke S (2025) The calcimimetic R568 reduces vascular smooth muscle cell calcification in vitro via ERK 1/2 phosphorylation. Int J Nephrol 2025:2492846. https://doi.org/10.1155/ijne/2492846

Article  CAS  PubMed  PubMed Central  Google Scholar 

de la Puente-Secades S, Mikolajetz D, Gayrard N, Hermann J, Jankowski V et al (2025) Vasoconstriction-inhibiting factor: an endogenous inhibitor of vascular calcification as a calcimimetic of calcium-sensing receptor. Cardiovasc Res 121:507–521. https://doi.org/10.1093/cvr/cvaf016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trial Investigators EVOLVE, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TCH, Moe SM, Trotman ML, Wheeler DC, Parfrey PS (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367:2482–2494. https://doi.org/10.1056/NEJMoa1205624

Article  Google Scholar 

Akizawa T, Kurita N, Mizobuchi M, Fukagawa M, Onishi Y, Yamaguchi T, Ellis AR, Fukuma S, Alan Brookhart M, Hasegawa T, Kurokawa K, Fukuhara S (2016) PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism. Sci Rep 6:19612. https://doi.org/10.1038/srep19612

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gillespie IA, Floege J, Gioni I, Drüeke TB, de Francisco AL, Anker SD, Kubo Y, Wheeler DC, Froissart M (2015) Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of Cinacalcet use on all-cause mortality. Pharmacoepidemiol Drug Saf 24:738–747. https://doi.org/10.1002/pds.3789

Article  CAS  PubMed  PubMed Central  Google Scholar 

Block GA, Zaun D, Smits G, Persky M, Brillhart S, Nieman K, Liu J, St Peter WL (2010) Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients. Kidney Int 78:578–589. https://doi.org/10.1038/ki.2010.167

Article  CAS  PubMed  Google Scholar 

Zu Y, Lu X, Song J, Yu L, Li H, Wang S (2019) Cinacalcet treatment significantly improves all-cause and cardiovascular survival in dialysis patients: results from a meta-analysis. Kidney Blood Press Res 44:1327–1338.